Skip to content
healthcare.dev

Abirtega

NDC 82249-011, Abiraterone acetate, tablet, from CivicaScript, LLC.

Product NDC
82249-011
Status
Listed
Labeler
CivicaScript, LLC
Dosage form
TABLET
Route
ORAL, ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208339
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82249-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
82249-011-1282249001112120 TABLET in 1 BOTTLE, PLASTIC (82249-011-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2f932015-28b2-4f44-ac04-772e982e13e9
  • NADAC price for package 82249001112

    GET /v1/drugs/nadac/82249001112

Use it

Look up 82249-011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82249-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82249-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.